Literature DB >> 16563672

In vitro characterization and transfection of IL-2 gene complexes.

Güzin Ozgel1, Jülide Akbuğa.   

Abstract

BACKGROUND: Interleukin-2 used in the treatment of malignant tumors has an anti-tumor efficacy. In this study, we have studied in vitro characterization and transfection efficiency of a plasmid encoding hIL-2, pCXWN-hIL-2, complexed to chitosan, polyethylenimine or DOTAP with varying ratios.
METHODS: Plasmid DNA was amplified in Escherichia coli DH5alpha and isolated by alkali lysis method. The pDNA/chitosan, pDNA/PEI or pDNA/DOTAP complexes were analyzed by agarose gel electrophoresis for complex formation and by ESEM image analysis system for the morphology and DNA/medium relationship of complexes. DNase stability, the particle size and zeta potential values of complexes were determined. Transfection efficiencies of resulting complexes in two different cell lines were assayed by ELISA method.
RESULTS: Conclusively, a transfection activity was observed in both cell lines (HeLa and Swiss3T3) with the order of pDNA/DOTAP>pDNA/PEI>pDNA/chitosan complexes. We have observed that the transfection efficiency was higher in HeLa cell line compared to Swiss3T3 cell line.
CONCLUSION: The physicochemical studies like stability, particle size and zeta potential, showed a relationship between the properties of a complex and its transfection efficiency.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16563672     DOI: 10.1016/j.ijpharm.2006.02.013

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Enhanced gene delivery mediated by low molecular weight chitosan/DNA complexes: effect of pH and serum.

Authors:  Surendra Nimesh; Marc M Thibault; Marc Lavertu; Michael D Buschmann
Journal:  Mol Biotechnol       Date:  2010-10       Impact factor: 2.695

2.  Increased in vitro Cell Proliferation by Chitosan/pGM-CSF Complexes.

Authors:  E Salva; S O Turan; J Akbuğa
Journal:  Indian J Pharm Sci       Date:  2011-03       Impact factor: 0.975

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.